Linda Filler

October 17, 2026

Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.

October 17, 2026

Veralto Sets Date for Q3 2026 Earnings Call. Veralto has announced the schedule for its third-quarter 2026 earnings call, providing investors with a specific date to review upcoming financial results. This announcement is a standard corporate disclosure that helps the market prepare for the next major update on the company's performance. The stock is currently trading near its 52-week high, reflecting strong recent momentum ahead of this scheduled event.

October 17, 2026

Carlyle Schedules Q3 Earnings as Shares Fall and Targets Cut. Carlyle Secured Lending has scheduled its Q3 earnings release and conference call for the quarter ended September 30, 2026. In recent trading, the company's shares fell, as reported in a market roundup. Analysts at UBS and TD Cowen lowered their price targets to $60 and $42, citing concerns such as the risk of private‑credit exposure to a growing AI financing wave that Carlyle highlighted.